Physician profile
Loretta Frank
NPI 1609835503
$1,221.76
in general payments reported to CMS, 2019-2025
14 companies · $93.76 in 2025
The $93.76 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $493 · 2023: $359 · 2024: $120 · 2025: $93.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $119.77 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.99 | 2022 | |
| Alnylam Pharmaceuticals INC. | $107.02 | 2023 | Givlaari |
| Biohaven Pharmaceuticals, INC. | $106.23 | 2021 | |
| Atricure, INC. | $104.93 | 2023 | |
| Abbvie INC. | $100.26 | 2022 | |
| Novo Nordisk INC | $100.01 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $95.46 | 2022 | |
| Genzyme Corporation | $93.76 | 2025 | |
| Biogen, INC. | $84.61 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.53 | 2023 | |
| Amgen INC. | $60.51 | 2022 | |
| Sk Life Science, INC. | $49.82 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loretta Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.